Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...
The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Fulfilling the Promise of Noninvasive Brain Stimulation as a Precision Medicine Tool” on Tuesday, January 14, 2025, at 2:00 ...
The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...
Children and young people with high levels of mental health needs are struggling to receive the help they need, or to have their difficulties recognized, according to a new study.
The Brain & Behavior Research Foundation (BBRF) has announced the 2024 Leading Research Achievements by BBRF grantees, prizewinners, and scientific council members. It includes important studies of ...